World News: 09:05 GMT Monday 6th August 2018. [ASLAN Pharmaceuticals Limited via Globe Newswire via SPi World News]
SINGAPORE Aug 06 2018 GLOBE NEWSWIRE -- ASLAN Pharmaceuticals NASDAQASLN TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe , today...
Globe Newswire: 09:05 GMT Monday 6th August 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.